+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

The role of N-glycosylation in function and surface trafficking of the human dopamine transporter

The role of N-glycosylation in function and surface trafficking of the human dopamine transporter

Journal of Biological Chemistry 279(20): 21012-21020

The present study addressed the role of N-linked glycosylation of the human dopamine transporter (DAT) in its function with the help of mutants, in which canonical N-glycosylation sites have been removed (N181Q, N181Q,N188Q, and N181Q,N188Q,N205Q), expressed in human embryonic kidney-293 cells. Removal of canonical sites produced lower molecular weight species as did enzymatic deglycosylation or blockade of glycosylation, and all three canonical sites were found to carry sugars. Prevention of N-glycosylation reduced both surface and intracellular DAT. Although partially or non-glycosylated DAT was somewhat less represented at the surface, no evidence was found for preferential exclusion of such material from the plasma membrane, indicating that glycosylation is not essential for DAT expression. Non-glycosylated DAT was less stable at the surface as revealed by apparently enhanced endocytosis, consonant with weaker DAT immunofluorescence at the cell surface and stronger presence in cytosol in confocal analysis of the double and triple mutant. Non-glycosylated DAT did not transport dopamine as efficiently as wild-type DAT as judged from the sharp reduction in uptake V(max), and prevention of N-glycosylation enhanced the potency of cocaine-like drugs in inhibiting dopamine uptake into intact cells without changing their affinity for DAT when measured in membrane preparations prepared from these cells. Thus, non-glycosylated DAT at the cell surface displays appreciably reduced catalytic activity and altered inhibitor sensitivity compared with wild type.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 012677004

Download citation: RISBibTeXText

PMID: 15024013

DOI: 10.1074/jbc.M311972200

Related references

Biosynthesis, N-glycosylation, and surface trafficking of biogenic amine transporter proteins. Methods in Enzymology 296: 347-370, 1998

The Human Scavenger Receptor CD36: glycosylation status and its role in trafficking and function. Journal of Biological Chemistry 284(24): 16277-16288, 2009

1-Methyl-4-phenylpyridinium-induced down-regulation of dopamine transporter function correlates with a reduction in dopamine transporter cell surface expression. Biochemical & Biophysical Research Communications 311(1): 49-54, November 7, 2003

Role of N-linked glycosylation in biosynthesis, trafficking, and function of the human glucagon-like peptide 1 receptor. American Journal of Physiology. Endocrinology and Metabolism 299(1): E62-E68, 2010

Dopamine and amphetamine rapidly increase dopamine transporter trafficking to the surface: live-cell imaging using total internal reflection fluorescence microscopy. Journal of Neuroscience 29(10): 3328-3336, 2009

The role of N-glycosylation in the biosynthesis, stability and function of the human norepinephrine transporter. Society for Neuroscience Abstracts 20(1-2): 627, 1994

Oligomerization and trafficking of the human dopamine transporter. Mutational analysis identifies critical domains important for the functional expression of the transporter. Journal of Biological Chemistry 278(4): 2731-2739, 2002

Dopamine transporter PET in normal aging: dopamine transporter decline and its possible role in preservation of motor function. Synapse 64(2): 146-151, 2010

The plasma membrane-associated GTPase Rin interacts with the dopamine transporter and is required for protein kinase C-regulated dopamine transporter trafficking. Journal of Neuroscience 31(39): 13758-13770, 2011

The role of N-glycosylation for functional expression of the human platelet-activating factor receptor. Glycosylation is required for efficient membrane trafficking. Journal of Biological Chemistry 270(42): 25178-25184, 1995

N-linked glycosylation of human SLC1A5 (ASCT2) transporter is critical for trafficking to membrane. Biochimica et Biophysica Acta 1853(7): 1636-1645, 2015

A genetic screen in Caenorhabditis elegans for dopamine neuron insensitivity to 6-hydroxydopamine identifies dopamine transporter mutants impacting transporter biosynthesis and trafficking. Journal of Neurochemistry 94(3): 774-785, 2005

Substitution of carboxyl tail of bovine dopamine transporter for human dopamine transporter attenuates substrate transport and cocaine binding in human dopamine transporter. Society for Neuroscience Abstracts 23(1-2): 407, 1997

Role of N-glycosylation in the structure and function of the methotrexate membrane transporter from CCRF-CEM human lymphoblastic leukemia cells. Biochemical Pharmacology 47(6): 1094-1098, 1994